Coastal Investment Advisors Inc. downgrades shares in HCA Healthcare, Inc. (NYSE: HCA)


Coastal Investment Advisors Inc. reduced its stake in HCA Healthcare, Inc. (NYSE: HCA – Get Rating) by 22.8% in the first quarter, according to HoldingsChannel. The fund owned 1,249 shares of the company’s shares after selling 368 shares in the quarter. The holdings of Coastal Investment Advisors Inc. at HCA Healthcare were worth $ 313,000 at the end of the last quarter.

Several other institutional investors also made changes to their positions in the HCA. Commercial Bank raised its position in HCA Healthcare by 6.1% in the fourth quarter. Commercial Bank already owns 6,859 shares of the company’s shares worth $ 1,762,000 after buying an additional 392 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in shares of HCA Healthcare by 10.8% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 117,836 shares of the company’s stock worth $ 29,940,000 after purchasing an additional 11,453 shares during the period. Wolf Group Capital Advisors increased its stake in HCA Healthcare by 205.4% in the fourth quarter. Wolf Group Capital Advisors already owns 34,990 shares of the company’s stock worth $ 8,990,000 after purchasing an additional 23,533 shares during the period. TD Asset Management Inc. increased its stake in HCA Healthcare by 60.9% in the fourth quarter. TD Asset Management Inc. now owns 849,594 shares of the company’s stock worth $ 218,278,000 after purchasing an additional 321,524 shares during the period. Finally, ProShare Advisors LLC increased its stake in HCA Healthcare by 21.8% in the fourth quarter. ProShare Advisors LLC now owns 58,862 shares of the company’s stock worth $ 15,122,000 after purchasing an additional 10,528 shares during the period. 67.87% of the shares are currently owned by institutional investors and hedge funds.

Shares of HCA opened at $ 182.33 on Friday. The 50-day moving average business price is $ 209.33, and the 200-day moving average is $ 236.85. HCA Healthcare, Inc. has a 1-year low of $ 169.13 and a 1-year high of $ 279.02. The company has a market capitalization of $ 53.87 billion, a PE ratio of 8.58, a P / E / G ratio of 1.13 and a beta ratio of 1.61. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.43 and a fast ratio of 1.24.

HCA Healthcare (NYSE: HCA – Get Rating) last announced its quarterly earnings data on Friday, April 22nd. The company reported earnings of $ 4.12 per share for the quarter, lacking analysts’ consensus estimates of $ 4.27 s ($ 0.15). The business had revenue of $ 14.95 billion for the quarter, compared to analysts’ estimates of $ 14.72 billion. HCA Healthcare has a return on equity of 405.72% and a net profit of 11.40%. The company’s revenue increased by 6.9% on an annual basis. During the same period last year, the company earned $ 4.14 EPS. Stock analysts expect HCA Healthcare, Inc. will report 17.12 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 30. The record shareholders on Thursday, June 16, will receive a dividend of $ 0.56. This represents a $ 2.24 annual dividend and a yield of 1.23%. The date of the former dividend is Wednesday, June 15. The dividend payout ratio (DPR) of HCA Healthcare is 10.54%.

In other HCA Healthcare news, CEO Andrea B. Smith bought 1,160 shares of HCA Healthcare shares in a deal on Thursday, April 28th. The shares were purchased at an average price of $ 213.63 per share, for a total transaction of $ 247,810.80. Following the transaction, the director now owns 2,239 shares of the company’s stock worth approximately $ 478,317.57. The acquisition is disclosed in a document submitted to the Securities and Exchange Commission, which you can access through this link. Also, senior vice president Jennifer Beres sold 2,358 shares of the company’s shares in a deal on Friday, May 13. The shares were sold at an average price of $ 218.87, for a total value of $ 516,095.46. Following the sale, the senior vice president now owns 11,392 shares of the company’s stock worth $ 2,493,367.04. The disclosure for this sale can be found here. In the last three months, insiders acquired 91,370 shares of the company worth $ 19,373,375. 1.50% of the shares are owned by corporate insiders.

Several analysts recently released reports on the company. Oppenheimer set a price of $ 255.00 for HCA Healthcare in a research note on Monday, June 20th. Credit Suisse Group lowered its price target for HCA Healthcare from $ 296.00 to $ 260.00 and set a rating “superior” for the company in a research note on Monday, April 25. Royal Bank of Canada reduced its target for HCA Healthcare prices from $ 267.00 to $ 256.00 in a study note on Tuesday, June 21. Sanford C. Bernstein upgraded HCA Healthcare from a “market performance” rating to a “superior” rating and lowered its price target for the company from $ 273.00 to $ 271.00 in a survey note on Thursday, May 26th. Finally, Wells Fargo & Company lowered its target price for HCA Healthcare from $ 267.00 to $ 227.00 and set an “equal weight” rating for the company in a note from the survey on Monday, April 25th. Five research analysts rated the shares with a retention rating, and eighteen gave the company a rating to buy. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buying” and an average target price of $ 257.68.

Company Profile HCA Healthcare (Get a rating)

HCA Healthcare, Inc., through its subsidiaries, provides a health services company in the United States. The company operates general and emergency hospitals that offer medical and surgical services, including hospital care, intensive care, cardiac care, diagnostic and emergency services; and outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physiotherapy.

Recommended stories

Want to see what other hedge funds hold HCA? Visit HoldingsChannel.com to receive the latest 13F requests and internal deals for HCA Healthcare, Inc. (NYSE: HCA – Get rating).

Institutional ownership by quarter for HCA Healthcare (NYSE: HCA)



Receive news and reviews for HCA Healthcare Daily – Enter your email address below to receive a brief daily summary of the latest news and analyst ratings for HCA Healthcare and related companies with the FREE Daily Newsletter on MarketBeat.com.

Leave a Comment